Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Joseph P. Eder's publication output changed over time?
ScholarIQpublication output · 2014–2015
Output grew0% over the shown period — from 1 works in 2014 to 1 in 2015.
1
1
20142015
What are the most-cited papers on Joseph P. Eder?
ScholarIQmost cited works
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi
New England Journal of Medicine. 20156,260 CitationsOPEN ACCESS
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles, Joseph P. Eder, Gregg Fine, Fadi S. Braiteh, Yohann Loriot, Cristina Cruz, Joaquim Bellmunt, Howard A. Burris, Daniel P. Petrylak, Siew-leng Melinda Teng, Xiaodong Shen, Zachary Boyd, Priti S. Hegde, Daniel S. Chen, Nicholas J. Vogelzang
Nature. 20142,426 Citations
Related on ScholarIQ
Yale Cancer Center
University
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Paper
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Paper
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Research Studies
Topic